You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC. (D.N.J. 2015)


✉ Email this page to a colleague

« Back to Dashboard


BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC. (D.N.J. 2015)

Docket ⤷  Try a Trial Date Filed 2015-03-05
Court District Court, D. New Jersey Date Terminated 2017-04-18
Cause 35:271 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties BIOMARIN PHARMACEUTICAL INC.; MERCK & CIE; PAR PHARMACEUTICAL, INC.
Patents 7,566,462; 7,566,714; 7,612,073; 7,727,987; 7,947,681; 8,003,126; 8,067,416; 8,318,745; RE43,258; RE43,298; RE43,390; RE43,431; RE43,797
Attorneys CHARLES MICHAEL LIZZA; KATHERINE ANN ESCANLAR; SARAH ANN SULLIVAN; SEAN R. KELLY; WILLIAM C. BATON
Link to Docket External link to docket
Small Molecule Drugs cited in BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .
Biologic Drugs cited in BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC.
The biologic drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for BIOMARIN PHARMACEUTICAL INC. v. PAR PHARMACEUTICAL, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-03-05 1 expiration of U.S. Patent Nos. 7,566,462 (“the ’462 patent”), 7,566,714 (“the ’714 patent”), 7,612,073 (“…(“the ’073 patent”), 7,727,987 (“the ’987 patent”), 8,003,126 (“the ’126 patent”), 8,067,416 (“the ’416…’416 patent”), RE43,797 (“the ’797 patent”), and 8,318,745 (“the ’745 patent”) (collectively, the “patents-in-suit…Okhamafe. The ’797 patent is a reissue of U.S. Patent No. 7,947,681. A copy of the ’797 patent is attached … 1. This is an action for patent infringement under the patent laws of the United States, Title External link to document
2015-03-31 12 States Patent No. 7,566,462 (“the ’462 patent”); U.S. Patent No. 7,566,714 (“the ’714 patent”); U.S.…expiration of U.S. Patent Nos. 7,566,462 (“the ’462 patent”), 7,566,714 (“the ’714 patent”), 7,612,073 (…U.S. Patent No. 7,612,073 (“the ’073 patent”); U.S. Patent No. 7,727,987 (“the ’987 patent”); U.S. Patent…,126 (“the ’126 patent”); U.S. Patent No. 8,067,416 (“the ’416 patent”); U.S. Patent No. RE 43,797 (…the ’797 patent); and U.S. Patent No. 8,318,745 (“the ’745 patent”) (collectively, “the Patents-in-Suit External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.